The AIDS and AIDS-Related Research [AARR] IRG reviews all - basic, translational, clinical, and behavioral – aspects of HIV/AIDS research. This includes studies of: the molecular and cell biology, immunology, pathogenesis, and epidemiology of HIV and related viruses, as well as AIDS-associated opportunistic infections; the development of drugs, vaccines, and other therapies; complications of therapy, as well as behavioral and social science approaches to preventing and evaluating the consequences of HIV/AIDS.
The following study sections are included within the AARR IRG:
All AIDS-related applications are reviewed on an expedited cycle due to a Congressional mandate, and are therefore reviewed by one of the following study sections within the AARR IRG or by Special Emphasis Panels. AIDS-related applications that are appropriate for review by any of the other CSR study sections cannot be referred there due to the differences in the receipt and review dates within the review cycle. The VACC study section formerly reviewed all vaccine-related applications. However, the reorganization of the Immunology [IMM] IRG and the establishment of the Vaccines Against Microbial Diseases [VMD] study section has changed this referral pattern. Only applications with research directed to HIV/AIDS vaccines are assigned to AARR/VACC. Applications focusing on vaccine development for other infectious diseases are assigned to the Immunology IRG.